-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PqEhQdO/mmsUM9xeqI0neTbYwUdgQ5RymDnq5UxmcaJCji8xgxiyW5zv9nT4ENZ8 ckuwyPpBVPn+YgYgnth1Dg== 0001021408-02-005197.txt : 20020416 0001021408-02-005197.hdr.sgml : 20020416 ACCESSION NUMBER: 0001021408-02-005197 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIDAMED INC CENTRAL INDEX KEY: 0000929900 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 770314454 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-26082 FILM NUMBER: 02609553 BUSINESS ADDRESS: STREET 1: 46107 LANDING PARKWAY STREET 2: SUITE 101 CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 5104924900 MAIL ADDRESS: STREET 1: 46107 LANDING PARKWAY STREET 2: STE 101 CITY: FREMONT STATE: CA ZIP: 94538 15-12G 1 d1512g.txt FORM 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------------------- FORM 15 -------------------------- Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934. Commission File Number: 0-26082 MEDTRONIC VIDAMED, INC. (Exact name of registrant as specified in its charter) 710 Medtronic Parkway Minneapolis, MN 55432-5604 (763) 514-4000 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Common Stock, par value $.001 per share (Title of each class of securities covered by this Form) None (Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [_] Rule 12g-4(a)(1)(ii) [_] Rule 12h-3(b)(2)(i) [_] Rule 12g-4(a)(2)(i) [_] Rule 12h-3(b)(2)(ii) [_] Rule 12g-4(a)(2)(ii) [_] Rule 15d-6 [_] Rule 12h-3(b)(1)(i) [_] Approximate number of holders of record as of the certification or notice date: One Pursuant to the requirements of the Securities Exchange Act of 1934, Medtronic VidaMed, Inc., f/k/a VidaMed, Inc., has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person. Date: April 12, 2002 MEDTRONIC VIDAMED, INC. By: /s/ David J. Scott ---------------------------------- Name: /s/ David J. Scott -------------------------------- Title: Vice President and Secretary ------------------------------- -----END PRIVACY-ENHANCED MESSAGE-----